ACAD FY 2014 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

ACADACADIA Pharmaceuticals Inc.

$4B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$120,000-89.5% YoY

Gross Profit

-$60M-50401.7% margin

Operating Income

-$93M-77691.7% margin

Net Income

-$92M-77062.5% margin

EPS (Diluted)

$-0.95

Cash Flow

Operating Cash Flow

-$66M

Free Cash Flow

-$67M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$325M

Total Liabilities

$16M

Stockholders' Equity

$309M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$120,000	$1M	-89.5%
Gross Profit	-$60M	-$26M	-136.5%
Operating Income	-$93M	-$38M	-143.4%
Net Income	-$92M	-$38M	-143.7%